SCHEMBL1946324

SCHEMBL1946324

O=C/C=N/Nc1cccc(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DEPTOR Q8TB45 1/20 0.47
▸ KMT2A Q03164 4/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ RAB9A P51151 4/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ MMP2 P08253 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ MMP1 P03956 2/20 0.39
▸ MMP9 P14780 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ RAPGEF4 Q8WZA2 1/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28765244 1.00 DEPTOR (0.47) DEPTORKMT2AMEN1RAB9ANPC1
SCHEMBL29597278 1.00 DEPTOR (0.47) DEPTORKMT2AMEN1RAB9ANPC1
SCHEMBL22968457 0.81 DEPTOR (0.46) DEPTORKMT2AMEN1RAB9ANPC1
SCHEMBL29596251 0.81 DEPTOR (0.46) DEPTORKMT2AMEN1RAB9ANPC1
SCHEMBL32681965 0.78 GAA (0.47) DEPTORKMT2AMEN1RAB9ANPC1
SCHEMBL28765243 0.78 GAA (0.47) DEPTORKMT2AMEN1RAB9ANPC1
SCHEMBL680401 0.77 GAA (0.45) KMT2AMEN1RAB9ANPC1CA9
SCHEMBL680400 0.77 GAA (0.45) KMT2AMEN1RAB9ANPC1CA9
SCHEMBL22968440 0.77 DEPTOR (0.43) DEPTORKMT2AMEN1RAB9ANPC1
SCHEMBL29711854 0.77 DEPTOR (0.43) DEPTORKMT2AMEN1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114555603-B Improved synthetic methods for preparing (2H-1, 2, 3-triazol-2-yl) phenyl compounds as orexin receptor modulators 詹森药业有限公司 2025-03-14 — — CN claimed
CN-114555603-A Improved synthesis for the preparation of (2H-1,2, 3-triazol-2-yl) phenyl compounds as orexin receptor modulators 詹森药业有限公司 2022-05-27 — — CN claimed
CN-114555603-B Improved synthetic methods for preparing (2H-1, 2, 3-triazol-2-yl) phenyl compounds as orexin receptor modulators 詹森药业有限公司 2025-03-14 — — CN disclosed
EP-4010325-A1 IMPROVED SYNTHETIC METHODS OF MAKING (2H-1,2,3-TRIAZOL-2-YL)PHENYL COMPOUNDS AS OREXIN RECEPTOR MODULATORS Janssen Pharmaceutica NV (BE) 2022-06-15 — — EP disclosed
CN-114555603-A Improved synthesis for the preparation of (2H-1,2, 3-triazol-2-yl) phenyl compounds as orexin receptor modulators 詹森药业有限公司 2022-05-27 — — CN disclosed
WO-2021023843-A1 IMPROVED SYNTHETIC METHODS OF MAKING (2H-1,2,3-TRIAZOL-2-YL)PHENYL COMPOUNDS AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2021-02-11 — — WO disclosed
US-20110130406-A1 PYRAZOLO-PYRIDINES AS TYROSINE KINASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2011-06-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130406-A1 PYRAZOLO-PYRIDINES AS TYROSINE KINASE INHIBITORS TYRO3, LCK, LTK DEPTOR 3086/4885KMT2A 3787/4885MEN1 2342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback